Document is current

Any future updates will be listed below

The combination of dendritic cells-cytotoxic T lymphocytes/cytokine-induced killer (DC-CTL/CIK) therapy exerts immune and clinical responses in patients with malignant tumors

Crossref DOI link: https://doi.org/10.1186/s40164-015-0027-9

Published Online: 2015-11-10

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark